Cell Uptake and Validation of Novel PECs for Biomedical Applications
Author(s) -
Ilaria Elena Palamà,
Mariarosaria Musarò,
Addolorata M. L. Coluccia,
Stefania D’Amone,
Giuseppe Gigli
Publication year - 2011
Publication title -
journal of drug delivery
Language(s) - English
Resource type - Journals
eISSN - 2090-3014
pISSN - 2090-3022
DOI - 10.1155/2011/203676
Subject(s) - allylamine , polyelectrolyte , fluorescein , trypan blue , fluorescein isothiocyanate , conjugate , hydrochloride , chemistry , viability assay , chromatography , scanning electron microscope , fluorescence microscope , confocal microscopy , fluorescence , biophysics , nanotechnology , cell , materials science , biochemistry , biology , organic chemistry , polymer , mathematical analysis , physics , mathematics , quantum mechanics , composite material , microbiology and biotechnology
This pilot study provides the proof of principle for biomedical application of novel polyelectrolyte complexes (PECs) obtained via electrostatic interactions between dextran sulphate (DXS) and poly(allylamine hydrochloride) (PAH). Scanning electron microscopy (SEM) and atomic force microscopy (AFM) showed that DXS/PAH polyelectrolyte complexes were Monodispersed with regular rounded-shape features and average diameters of 250 nm at 2 : 1 weight ratios of DXS/PAH. Fluorescently labelled DXS and fluorescein-isothiocyanate- (FITC-)conjugate DXS were used to follow cell uptake efficiency of PECs and biodegradability of their enzymatically degradable DXS-layers by using confocal laser scanning microscopy (CLSM). Moreover, quantitative MTT and Trypan Blue assays were employed to validate PECs as feasible and safe nanoscaled carriers at single-cell level without adverse effects on metabolism and viability.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom